• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际囊性纤维化远端肠道梗阻综合征前瞻性研究:相关因素和结局。

International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome.

机构信息

Hôpital Robert Debré, Paediatric Gastroenterology and Respiratory Department, CF Centre, University Paris 7, 75019 Paris, France.

Hôpital Robert Debré, Clinical Epidemiology Unit, 75019 Paris, France; Sorbonne Paris Cité, UMR-S1123, ECEVE, University Paris Diderot, 75019 Paris, France; Inserm U1123 and CIC-EC 1426, 75019 Paris, France.

出版信息

J Cyst Fibros. 2016 Jul;15(4):531-9. doi: 10.1016/j.jcf.2016.02.002. Epub 2016 Feb 23.

DOI:10.1016/j.jcf.2016.02.002
PMID:26927601
Abstract

BACKGROUND

Distal intestinal obstruction syndrome (DIOS) is a specific complication of cystic fibrosis.

METHODS

A study was performed in 10 countries to prospectively evaluate the incidence, associated factors, and treatment modalities in children and adults.

RESULTS

102 patients presented 112 episodes. The incidence of DIOS was similar in children and adults. Medical treatment failed only in cases of complete DIOS (11%). Children with meconium ileus had a higher rate of surgery for DIOS (15% vs. 2%, p=0.02). Complete DIOS entailed longer hospitalisation (4 [3; 7] days vs. 3 [1; 4], p=0.002). Delayed arrival at hospital and prior weight loss had a significant impact on the time needed for DIOS resolution. Associated CF co-morbidities for DIOS included meconium ileus (40% vs. 18%, p<0.0001), exocrine pancreatic insufficiency (92% vs. 84%, p=0.03), liver disease (22% vs. 12%, p=0.004), diabetes mellitus (49% vs. 25%, p=0.0003), and Pseudomonas aeruginosa (68% vs. 52%, p=0.01); low fibre intake and insufficient hydration were frequently observed. Female gender was associated with recurrent DIOS (75% vs. 52%, p=0.04), constipation with incomplete episodes (39% vs. 11%, p=0.03), and poor patient compliance in taking pancreatic enzyme therapy during complete episodes (25% vs. 3%, p=0.02).

CONCLUSION

DIOS is a multifactorial condition having a similar incidence in children and adults. We show that delayed arrival at hospital after the initial symptoms causes significant morbidity. Early recognition and treatment would improve the prognosis.

摘要

背景

远端肠梗阻综合征(DIOS)是囊性纤维化的一种特定并发症。

方法

在 10 个国家进行了一项研究,前瞻性评估了儿童和成人的发病率、相关因素和治疗方式。

结果

102 例患者出现 112 例次。DIOS 的发病率在儿童和成人中相似。仅在完全 DIOS(11%)的情况下,药物治疗才会失败。患有胎粪性肠梗阻的儿童因 DIOS 而接受手术的比例更高(15%比 2%,p=0.02)。完全 DIOS 导致住院时间延长(4 [3;7] 天比 3 [1;4],p=0.002)。延迟就诊和体重减轻与 DIOS 缓解所需时间有显著影响。与 DIOS 相关的 CF 合并症包括胎粪性肠梗阻(40%比 18%,p<0.0001)、外分泌胰腺功能不全(92%比 84%,p=0.03)、肝病(22%比 12%,p=0.004)、糖尿病(49%比 25%,p=0.0003)和铜绿假单胞菌(68%比 52%,p=0.01);经常观察到低纤维摄入和水分不足。女性与复发性 DIOS 相关(75%比 52%,p=0.04)、不完全发作时与便秘相关(39%比 11%,p=0.03)以及在完全发作时服用胰腺酶治疗的患者顺应性差(25%比 3%,p=0.02)。

结论

DIOS 是一种多因素疾病,在儿童和成人中的发病率相似。我们表明,初始症状后延迟就诊会导致显著的发病率。早期识别和治疗将改善预后。

相似文献

1
International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome.国际囊性纤维化远端肠道梗阻综合征前瞻性研究:相关因素和结局。
J Cyst Fibros. 2016 Jul;15(4):531-9. doi: 10.1016/j.jcf.2016.02.002. Epub 2016 Feb 23.
2
Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.囊性纤维化患者远端肠梗阻综合征的长期随访
World J Gastroenterol. 2015 Jan 7;21(1):318-25. doi: 10.3748/wjg.v21.i1.318.
3
High ambient temperature and risk of intestinal obstruction in cystic fibrosis.高环境温度与囊性纤维化患者肠梗阻的风险
J Paediatr Child Health. 2016 Apr;52(4):430-5. doi: 10.1111/jpc.13096.
4
Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS.通过一项关于 DIOS 发生率、特征和治疗的多中心研究来定义囊性纤维化中的 DIOS 和便秘。
J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):38-42. doi: 10.1097/MPG.0b013e3181a6e01d.
5
Gastrointestinal surgery in cystic fibrosis: a 20-year review.囊性纤维化的胃肠外科手术:一项20年的回顾。
J Pediatr Surg. 2014 Feb;49(2):280-3. doi: 10.1016/j.jpedsurg.2013.11.038. Epub 2013 Nov 18.
6
Long-term intestinal obstruction sequelae and growth in children with cystic fibrosis operated for meconium ileus: expectancies and surprises.因胎粪性肠梗阻接受手术的囊性纤维化患儿的长期肠梗阻后遗症与生长发育:预期与意外情况
J Pediatr Surg. 2018 Aug;53(8):1504-1508. doi: 10.1016/j.jpedsurg.2017.11.040. Epub 2017 Nov 15.
7
Distal intestinal obstruction syndrome in cystic fibrosis: presentation, outcome and management in a tertiary hospital (2007-2012).囊性纤维化患者的远端肠梗阻综合征:一家三级医院的临床表现、治疗结果及管理(2007 - 2012年)
ANZ J Surg. 2014 Oct;84(10):740-4. doi: 10.1111/ans.12397. Epub 2013 Nov 18.
8
Distal intestinal obstruction syndrome: a diagnostic and therapeutic challenge in cystic fibrosis.远端肠梗阻综合征:囊性纤维化的诊断与治疗挑战
J Pediatr (Rio J). 2020 Nov-Dec;96(6):732-740. doi: 10.1016/j.jped.2019.08.009. Epub 2019 Oct 22.
9
Nutrition and pancreatic enzyme intake in patients with cystic fibrosis with distal intestinal obstruction syndrome.患有远端肠梗阻综合征的囊性纤维化患者的营养与胰酶摄入情况
Nutr Clin Pract. 2015 Feb;30(1):134-7. doi: 10.1177/0884533614551838. Epub 2014 Oct 6.
10
Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation.囊性纤维化中的肠梗阻综合征:胎粪性肠梗阻、远端肠梗阻综合征和便秘。
Curr Gastroenterol Rep. 2011 Jun;13(3):265-70. doi: 10.1007/s11894-011-0185-9.

引用本文的文献

1
Spontaneous lung colonization in the cystic fibrosis rat model is linked to gastrointestinal obstruction.囊性纤维化大鼠模型中的自发性肺部定植与胃肠道梗阻有关。
mBio. 2025 Apr 9;16(4):e0388324. doi: 10.1128/mbio.03883-24. Epub 2025 Mar 5.
2
A 20-year case-series of distal intestinal obstruction syndrome at a state-wide cystic fibrosis service.一项针对全州囊性纤维化服务机构的远端肠梗阻综合征的20年病例系列研究。
ANZ J Surg. 2025 Jul-Aug;95(7-8):1446-1453. doi: 10.1111/ans.70005. Epub 2025 Mar 3.
3
Presentation, characteristics and management of obstructive intestinal conditions in cystic fibrosis.
囊性纤维化中梗阻性肠道疾病的表现、特征及管理
Frontline Gastroenterol. 2024 Jan 6;15(3):222-227. doi: 10.1136/flgastro-2023-102533. eCollection 2024 May.
4
Mutational spectrum of CFTR in cystic fibrosis patients with gastrointestinal and hepatobiliary manifestations.囊性纤维化患者胃肠道和肝胆系统表现的 CFTR 基因突变谱。
Mol Biol Rep. 2024 Apr 25;51(1):573. doi: 10.1007/s11033-024-09508-3.
5
The current state of gastrointestinal motility evaluation in cystic fibrosis: a comprehensive literature review.囊性纤维化患者胃肠动力评估的现状:一项全面的文献综述
Transl Gastroenterol Hepatol. 2023 Dec 6;9:10. doi: 10.21037/tgh-23-59. eCollection 2024.
6
Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire.使用新型CFAbd-day2day问卷对接受依列卡福/替扎卡福/依伐卡福新疗法开始阶段腹部症状的动态变化研究
Front Pharmacol. 2023 Oct 25;14:1167407. doi: 10.3389/fphar.2023.1167407. eCollection 2023.
7
A Gastroenterologist's Guide to Care Transitions in Cystic Fibrosis from Pediatrics to Adult Care.《儿科至成人照护的囊性纤维化患者交接护理:胃肠病学家指南》
Int J Mol Sci. 2023 Oct 30;24(21):15766. doi: 10.3390/ijms242115766.
8
Effectiveness of an Oral Gastrografin Regimen for Complete Distal Intestinal Obstruction Syndrome.口服泛影葡胺方案治疗完全性远端肠梗阻综合征的疗效
Ann Surg Open. 2023 Apr 26;4(2):e279. doi: 10.1097/AS9.0000000000000279. eCollection 2023 Jun.
9
The NHE3 Inhibitor Tenapanor Prevents Intestinal Obstructions in CFTR-Deleted Mice.NHE3 抑制剂替那普仑可预防 CFTR 缺失小鼠的肠道梗阻。
Int J Mol Sci. 2022 Sep 1;23(17):9993. doi: 10.3390/ijms23179993.
10
Surgical considerations in cystic fibrosis: what every general surgeon needs to know.囊性纤维化的外科考虑因素:普通外科医生需要了解的知识。
ANZ J Surg. 2022 Oct;92(10):2425-2432. doi: 10.1111/ans.17948. Epub 2022 Aug 3.